Quick Answer
ASPEN AEROGELS INC reported Operating Income Loss of -$378.23 million for the year ending 2025.
- ASPEN AEROGELS INC showed a decrease of -793.6% in Operating Income Loss from 2024 to 2025.
- This data is from ASPEN AEROGELS INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$2.90 million | Q2 2014: -$8.12 million | Q3 2014: -$2.37 million | Q4 2014: -$2.66 million | Q1 2015: -$2.75 million | Q2 2015: -$2.69 million | Q3 2015: -$2.48 million | Q4 2015: $1.68 million | Q1 2016: -$1.76 million | Q2 2016: -$1.35 million | Q3 2016: -$2.40 million | Q4 2016: -$5.71 million | Q1 2017: -$9.05 million | Q2 2017: -$5.43 million | Q3 2017: -$3.03 million | Q4 2017: -$1.62 million | Q1 2018: -$6.75 million | Q2 2018: -$6.86 million | Q3 2018: -$6.37 million | Q4 2018: -$13.94 million | Q1 2019: -$5.96 million | Q2 2019: -$5.22 million | Q3 2019: -$2.15 million | Q4 2019: -$830.0 thousand | Q1 2020: -$3.09 million | Q2 2020: -$5.65 million | Q3 2020: -$6.70 million | Q4 2020: -$6.13 million | Q1 2021: -$6.18 million | Q2 2021: -$6.61 million | Q3 2021: -$11.50 million | Q1 2022: -$18.62 million | Q2 2022: -$22.65 million | Q3 2022: -$28.31 million | Q1 2023: -$18.91 million | Q2 2023: -$17.04 million | Q3 2023: -$14.63 million | Q1 2024: $2.44 million | Q2 2024: $19.99 million | Q3 2024: $17.40 million | Q1 2025: -$299.34 million | Q2 2025: -$5.16 million | Q3 2025: -$3.35 million.
- Over the full 14 years of available data (2012 to 2025), ASPEN AEROGELS INC's Operating Income Loss has declined by 1,047.1%.
- Historical annual values: Fiscal year 2025: -$378.23 million | Fiscal year 2024: $54.54 million | Fiscal year 2023: -$49.20 million | Fiscal year 2022: -$79.25 million | Fiscal year 2021: -$40.60 million | Fiscal year 2020: -$21.57 million | Fiscal year 2019: -$14.16 million | Fiscal year 2018: -$33.92 million | Fiscal year 2017: -$19.14 million | Fiscal year 2016: -$11.22 million | Fiscal year 2015: -$6.24 million | Fiscal year 2014: -$16.04 million | Fiscal year 2013: -$19.97 million | Fiscal year 2012: -$32.97 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: